This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Kennedy Jr. Medical and scientific groups have pushed back against this characterization.
Bancel is in the process of donating a vast majority of his income to charities. That CEO haul was down 11% from the $4.5 billion recorded in 2021. The 10 highest-paid CEOs — a list that also includes the CEOs of Thermo Fisher and McKesson — made a combined $1.4 billion, or about a third of the total studied.
Pharmacy has drastically changed, and with the patient view of most pharmacists just 'Count-Lick-and Pour' medications for patients it's not hard then to think of how to just automate the process. One issue is that the dispensing process is not a full-proof system at the current time. Which, to be honest, is a thing right now.
Pharmacists prescribe vaccinations. Separately, I don’t believe that 90-day supplies actually drive true adherence or clinical improvement - they just move the process measure of PDC. It’s also an error to believe that health insurers care about their members’ health. The authority to prescribe (i.e.
Initiatives such as Ayushmaan Bharat Digital Mission (“ADBDM”), CoWIN (a digital vaccine delivery platform), health registry, and telemedicine, highlight the government’s strong emphasis on digitisation of health in India. For pharma and medical devices policies, the Department of Pharmaceutical is the nodal agency. –
These platforms are designed for safe drug production while allowing scaleable manufacturing processes. mRNA vaccinecoverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. The trial data indicated dose-dependent protein production at the site without systemic bioavailability. “By
Communication and Transparency Clear Communication : We emphasize the need for documents to clearly and effectively communicate the nuances of the MPPP to beneficiaries, aiding in their decision-making process.
Biogenerics comes with higher risks, as the manufacturing process and technologies are more complex. There is also a nod to India’s vaccine dominance which came to prominence during the global COVID pandemic. The DoP report also points out that biogenerics need different approaches to deal with IP challenges.
Now, as vaccination continues at pace, the sector has pledged to help “build back better”, by lowering barriers between medical innovations and the patients who need them. As this report demonstrates, the biopharmaceutical indusyry is ready and willing to play its part in this process. Read the full report here. About the author.
If this applies to you, then you can begin your application process here to get the process started. Medicare Part D has four phases of coverage that users need to be aware of before and during enrollment in the program. In 2022, the initial coverage limit was $4,430. In 2022, the coverage gap limit was $7,050.
Its continuity and expertise are essential to ensuring that vaccine recommendations are based on the best available science-based evidence. Vaccination schedules must be grounded in scientific evidence, developed transparently, and implemented consistently.
Or perhaps it’s the constant back-and-forth with insurance companies over coverage? This could be attributed to various factors, including the stage of career development and the process of finding professional fulfillment. Share your thoughts down below! Feel free to check it out!
Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.
They primarily focus on improving the public health infrastructure, improving the development of treatment and vaccines, and coordinating federal response. These flexibilities and partnerships greatly increased the speed of research and development for COVID-19 testing, treatment, and vaccines.
Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. Until now, the vaccine was licensed for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 years and older.
As these technologies become increasingly integral to patient care, it is essential for CMS to develop clear and consistent guidelines for the payment and coverage of AI-enabled services. Providing clear guidance, technical assistance, and streamlined processes can help facilitate the adoption of this innovative care model.
Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines The Union Budget 2025 reinforces India’s commitment to innovation, healthcare accessibility, and womens empowerment. The recommendation to allow up to 100 per cent FDI in insurance can be a complementary to the focus on enhancing access to cancer care.
Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. lev radin via Shutterstock. lev radin via Shutterstock. Data Insights The gold standard of business intelligence.
The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. Second, it does not address the core issues of higher prices, such as the use of rebates by insurers.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content